Lanxess schedules November 5 results. Lanxess stock sits 45.87 percent below its high

Published on 10/26/2026 at 17:01 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

EBITDA guidance spans EUR 450-550 million for 2026. Lanxess stock costs EUR 11.92 on October 26, 2026, up 0.34 percent versus Xetra close.

Operating and market facts

Lanxess scheduled its third-quarter results for November 5, 2026.
EBITDA guidance for fiscal year 2026 spans EUR 450.00 million to EUR 550.00 million.
Lanxess stock costs EUR 11.92 at Lang & Schwarz on October 26, 2026 at 4:47 p.m. CEST, 0.34 percent above the Xetra close.

Lanxess, DE0005470405, Illustration mit AI erstellt.

Lanxess (ISIN DE0005470405) has scheduled its third-quarter 2026 results for November 5, 2026, with an investor call at 1:00 p.m. CEST, according to LANXESS. The company is preparing to report after a second quarter in which sales rose to EUR 1.56 billion, according to the same investor page. At Lang & Schwarz on October 26, 2026 at 4:47 p.m. CEST, Lanxess stock was trading at EUR 11.92, up 0.34 percent versus the Xetra close of October 26, 2026 at EUR 11.88.

Guidance sets the next test

Lanxess lists fiscal-year 2026 EBITDA guidance of EUR 450.00 million to EUR 550.00 million. The range gives the November results a clear operating benchmark, because the company will need to show how sales growth is translating into earnings and cash generation. The guidance is identified in a recent filing overview from TradingView.

What does the price position say?

Lanxess stock stood 8.07 percent above its 52-week low of EUR 11.03 and 45.87 percent below its 52-week high of EUR 22.02 on October 26, 2026. Trading volume was 430,559 shares, while market capitalization stood at EUR 1.0 billion. The combination places the stock close to its yearly floor, even though the daily move against Xetra was positive.

Valuation and reporting date

The next formal company date is November 5, 2026. The investor page names that date for the third-quarter statement and management call. In a separate October 13 report, Yahoo Finance said modelled fair value had been reduced from EUR 16.77 to EUR 15.41, a cut of 8.11 percent. The revised figure was 29.28 percent above the October 26 Lang & Schwarz price.

Comparison with peers

Lanxess: up 0.34 percent, market capitalization EUR 1.0 billion.

BASF: down 0.23 percent, P/E 7.86, market capitalization EUR 45.1 billion.

Evonik Industries: up 0.28 percent, P/E 82.44, market capitalization EUR 9.9 billion.

Stock position before results

The November reporting date gives investors the next fixed checkpoint, while the wide gap to the 52-week high keeps the earnings release central to the stock's valuation debate. Lanxess is listed on Xetra and operates in specialty chemicals, including intermediates, additives and consumer protection products.

The further course of trading is shown by the continuously updated real-time quote of Lanxess stock.